Panpan Hou | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Panpan Hou | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Macau University Of Science And Technology | Macau

Assist. Prof. Dr. Panpan Hou is a distinguished researcher in the field of Biomedical Engineering and Biophysics, with a prolific record of 375 documents, 541 citations, and an h-index of 16. After obtaining a B.S. in Biomedical Engineering and a Ph.D. in Biophysics from Huazhong University of Science and Technology, Dr. Hou completed postdoctoral training at Washington University in St. Louis before joining Macau University of Science and Technology as an Assistant Professor in 2021. Dr. Hou’s research focuses on ion channel physiology, voltage-sensor domain (VSD) mechanisms, and electro-mechanical coupling, elucidating complex molecular processes such as the VSD-pore coupling in KCNQ1 channels and identifying novel modulators with therapeutic potential. He has made significant contributions to drug screening, cardiovascular disease modeling, and electrophysiology, publishing high-impact work in journals including Nature Communications, PNAS, eLife, Circulation Research, and Scientific Reports. Dr. Hou has received multiple awards including the AHA Postdoctoral Fellowship, Best Poster Awards at international symposia, and the 2025 Best Research Output Award from Macau University of Science and Technology. Beyond research, he actively mentors students, serves on editorial boards, and contributes to national and international scientific societies. With a strong track record of innovation, mentorship, and high-impact publications, Dr. Hou exemplifies excellence in biomedical research and is poised to advance the understanding of ion channel physiology and therapeutic interventions.

Profiles : Scopus | Orcid | Google Scholar

Featured Publications

Zhong, L., Lin, X., Cheng, X., Wan, S., Hua, Y., Nan, W., Hu, B., Peng, X., Zhou, Z., Zhang, Q., Yang, H., Noé, F., Yan, Z., Jiang, D., Zhang, H., Liu, F., Xiao, C., Zhou, Z., Mou, Y., Yu, H., Ma, L., Huang, C., Wong, V. K. W., Chung, S. K., Shen, B., Jiang, Z.-H., Neher, E., Zhu, W., Zhang, J., & Hou, P. (2025). Secondary structure transitions and dual PIP2 binding define cardiac KCNQ1-KCNE1 channel gating. Cell Research.

Hou, P., Zhao, L., Zhong, L., Shi, J., Wang, H. Z., Gao, J., Liu, H., Zuckerman, J., Cohen, I. S., & Cui, J. (2024). The fully activated open state of KCNQ1 controls the cardiac “fight-or-flight” response. PNAS Nexus.

Liu, Y., Xu, X., Gao, J., Naffaa, M. M., Liang, H., Shi, J., Wang, H. Z., Yang, N.-D., Hou, P., & Zhao, W. (2022). Author correction: A PIP2 substitute mediates voltage sensor-pore coupling in KCNQ activation. Communications Biology.

Dou, A., Kang, P. W., Hou, P., Zaydman, M. A., Zheng, J., Jegla, T., & Cui, J. (2021). Principles of sensor-effector organization in six-transmembrane ion channels.

Lin, Y., Grinter, S. Z., Lu, Z., Xu, X., Wang, H. Z., Liang, H., Hou, P., Gao, J., Clausen, C., & Shi, J. (2021). Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects. Proceedings of the National Academy of Sciences.

Liu, Y., Xu, X., Gao, J., Naffaa, M. M., Liang, H., Shi, J., Wang, H. Z., Yang, N.-D., Hou, P., & Zhao, W. (2020). A PIP2 substitute mediates voltage sensor-pore coupling in KCNQ activation. Communications Biology.

Taylor, K. C., Kang, P. W., Hou, P., Yang, N.-D., Kuenze, G., Smith, J. A., Shi, J., Huang, H., McFarland White, K., & Peng, D. (2020). Structure and physiological function of the human KCNQ1 channel voltage sensor intermediate state. eLife.

Hou, P., Kang, P. W., Kongmeneck, A. D., Yang, N.-D., Liu, Y., Shi, J., Xu, X., McFarland White, K., Zaydman, M. A., Kasimova, M. A., Seebohm, M., Zhong, L., Zou, X., Tarek, M., & Cui, J. (2020). Two-stage electro–mechanical coupling of a KV channel in voltage-dependent activation. Nature Communications.

Zhu, W., Mazzanti, A., Voelker, T. L., Hou, P., Moreno, J. D., Angsutararux, P., Naegle, K. M., Priori, S. G., & Silva, J. R. (2019). Predicting patient response to the antiarrhythmic mexiletine based on genetic variation: Personalized medicine for long QT syndrome. Circulation Research.

Hou, P., Kang, P. W., Kongmeneck, A. D., Yang, N.-D., Liu, Y., Shi, J., Xu, X., McFarland White, K., Zaydman, M. A., Kasimova, M. A., Seebohm, M., Zhong, L., Zou, X., Tarek, M., & Cui, J. (2019). Two-stage electro-mechanical coupling of a KV channel in voltage-dependent activation.

Hou, P., Shi, J., McFarland White, K., Gao, Y., & Cui, J. (2019). ML277 specifically enhances the fully activated open state of KCNQ1 by modulating VSD-pore coupling. eLife.

Hou, P., Shi, J., McFarland White, K., Gao, Y., & Cui, J. (2019). ML277 specifically enhances pore opening of KCNQ1 with VSD at the activated state by modulating VSD-pore coupling.

Hou, P., Eldstrom, J., Shi, J., Zhong, L., McFarland, K., Gao, Y., Fedida, D., & Cui, J. (2017). Inactivation of KCNQ1 potassium channels reveals dynamic coupling between voltage sensing and pore opening. Nature Communications.

Jin-Lu Huang | Pharmacology, Toxicology and Pharmaceutical Science | Best Scholar Award

Dr. Jin-Lu Huang | Pharmacology, Toxicology and Pharmaceutical Science | Best Scholar Award

Shanghai Sixth People's Hospital | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Dr. Jin-Lu Huang’s academic journey reflects a steadfast dedication to the pharmaceutical sciences. He began his higher education at Lin Yi University, earning a Bachelor’s Degree in Life Science in 2004. He then pursued a Master’s Degree in Microbiology and Biochemical Pharmacy at the China Pharmaceutical University, graduating in 2007. Driven by a passion for research, Dr. Huang completed his PhD in Pharmacy at Shanghai Jiao Tong University in 2012, laying the foundation for a research-intensive career in pharmacology and clinical applications.

💼 Professional Endeavors

Since July 2012, Dr. Huang has served as a Pharmacist at the Department of Pharmacy, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His clinical expertise is complemented by an earlier role (2007–2008) as a Researcher at Shanghai Hengrui Pharmaceutical Co., Ltd., where he was involved in cutting-edge drug development and R&D processes.

🔬 Contributions and Research Focus

Dr. Huang's research spans ionomic metabolism, neuropathic and bone cancer pain, drug-induced side effects, and hospital pharmaceutical practices. His work often bridges basic pharmacological science with clinical application, focusing on pain modulation, calcium signaling pathways, and drug safety evaluation. He has authored over 20 peer-reviewed articles, including high-impact studies on analgesic mechanisms, store-operated calcium entry in neuropathy, and bone cancer pain ionomics. Notably, many of his papers explore pain at a molecular level, offering insights into sphingosine-1-phosphate receptors, ionomic profiles, and nuclear receptor signaling pathways.

🏅 Accolades and Recognition

Dr. Huang is a respected member of several leading professional societies including the Chinese Pharmacological Society, the International Union of Basic and Clinical Pharmacology, and the British Pharmacological Society. His extensive publication record, both as a lead author and co-investigator, reflects international recognition and collaboration. His research has appeared in journals like FEBS Open BioPainScientific Reports, and Pharmaceutical Biology.

🌏 Impact and Influence

Dr. Huang's work has contributed significantly to the pharmacological understanding of chronic pain, particularly in the context of bone cancer and neuropathy. His analyses using bioinformatics tools like GoPubMed and his contributions to visualizing research trends have informed policy and practice in hospital pharmacy and drug safety evaluation. His studies are frequently referenced by fellow researchers and clinicians dealing with oncology-related pain and pharmaceutical practices in hospitals.

🔮 Legacy and Future Contributions

As a bridge between clinical pharmacy and laboratory research, Dr. Jin-Lu Huang is poised to leave a lasting legacy in translational pharmacology. With ongoing investigations into neuroinflammation, analgesic mechanisms, and metabolic responses to drug therapies, he continues to shape the future of personalized and precision medicine in pain management. His commitment to advancing both theoretical insights and clinical practices ensures that his contributions will benefit patients and healthcare systems for years to come.

 

Publications


  • 📄Involvement of ionomic metabolism of both the cerebrospinal fluid and the spinal cord in the analgesic efficacy of matrine in rats
    Authors: Huang JL, Tang CY, Fu Y, Wan LL, Li J, Sun XP, Hu JL, Zhang YY, Qu LY, Fu MJ, Zhang YY, Ma L, Guo C, Chen JG
    Journal: Pharmaceutical Biology
    Year: 2025

  • 📄Bckdk-Mediated Branch Chain Amino Acid Metabolism Reprogramming Contributes to Muscle Atrophy during Cancer Cachexia
    Authors: Chen L, Zhang H, Chi M, Guo C, Yang Q
    Journal: Molecular Nutrition and Food Research
    Year: 2024

  • 📄Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain
    Authors: Wang Q, Duan D, Luo C, Yang S, Ma L
    Journal: Annals of Medicine
    Year: 2024

  • 📄Analysis of Ionomic Profiles of Spinal Cords in a Rat Model with Bone Cancer Pain
    Authors: Huang JL, Chen JG, Ma L, Zhu XY, Wan LL, Li XY, Guo C
    Journal: Journal of Pain Research
    Year: 2024

  • 📄Store-operated calcium entry mediates hyperalgesic responses during neuropathy
    Authors: Wang W, Wang Q, Huang JL, Li H, Li F, Li X, Liu R, Xu M, Chen J, Mao Y, Ma L
    JournalFEBS Open Bio
    Year: 2023